TerminatedPhase 3NCT00266149
Lamotrigine and Oral Contraceptives
Studying Metabolic diseases with epilepsy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Aarhus
- Principal Investigator
- Jakob Christensen, MD, PhDDepartment of Neurology, Aarhus University Hospital, 8000 Aarhus C
- Intervention
- Oral contraception(drug)
- Enrollment
- 10 enrolled
- Eligibility
- 18-40 years · FEMALE
- Timeline
- 2003 – 2005
Study locations (1)
- Department of Neurology, Aarhus University Hospital, Aarhus, Aarhus, Denmark
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00266149 on ClinicalTrials.govOther trials for Metabolic diseases with epilepsy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07096414Effect of Vitamin D3 Supplementation on Brain Waves in Male Epileptic Patients With Hypovitaminosis DBangladesh Medical University
- RECRUITINGNANCT07085598Effect of Vitamin D3 Supplementation on Cardiac Autonomic Nerve Function in Male Epileptic Patients With Hypovitaminosis DBangladesh Medical University
- ENROLLING BY INVITATIONPHASE1, PHASE2NCT06369571Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins DietJohns Hopkins University
- ACTIVE NOT RECRUITINGNCT02694094Impact of Ketogenic Diets on Cardiovascular Health in Adults With EpilepsyJohns Hopkins University